Clinical Trial Update: Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating double simultaneous uterotonic agents versus a single-agent regimen to prevent early postpartum hemorrhage and is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• uterotonic agents

Snippet

Sponsor: Stony Brook University | Conditions: Postpartum Hemorrhage | Phase 3 | Status: RECRUITING